Article Details

Canopy Growth signs deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary

Retrieved on: 2021-12-15 18:00:49

Tags for this article:

Click the tags to see associated articles and topics

Canopy Growth signs deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary. View article details on hiswai:

Excerpt

Under the agreement, Canopy will receive an upfront payment of $115.5-million. The deal, which requires regulatory approvals, is expected to close ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up